Chemoinformaics analysis of 2-chloro- (CAS) 2- Chloropropane
| Molecular Weight | 92.569 | nRot | 0 |
| Heavy Atom Molecular Weight | 83.497 | nRig | 0 |
| Exact Molecular Weight | 92.0393 | nRing | 0 |
| Solubility: LogS | -1.785 | nHRing | 0 |
| Solubility: LogP | 1.929 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 14.8611 |
| nHD | 0 | BPOL | 9.53886 |
| QED | 0.401 |
| Synth | 2.114 |
| Natural Product Likeliness | -0.154 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.297 |
| MDCK | 0.0000231 |
| BBB | 0.988 |
| PPB | 0.827941 |
| VDSS | 1.963 |
| FU | 0.37648 |
| CYP1A2-inh | 0.746 |
| CYP1A2-sub | 0.89 |
| CYP2c19-inh | 0.176 |
| CYP2c19-sub | 0.883 |
| CYP2c9-inh | 0.049 |
| CYP2c9-sub | 0.487 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.555 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.324 |
| CL | 9.617 |
| T12 | 0.762 |
| hERG | 0.014 |
| Ames | 0.081 |
| ROA | 0.237 |
| SkinSen | 0.223 |
| Carcinogencity | 0.62 |
| EI | 0.994 |
| Respiratory | 0.891 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.954861 |